Q/C Technologies, Inc. (QCLS) stock
QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.33+0.01 (+4.05%)
Close on Nov 17, 2026Market cap $2.74MP/E –Yield –
Q/C Technologies gross margin
Gross margin is gross profit as a percentage of revenue.
Q/C Technologies's gross margin for the twelve months ending Jun 30, 2020 was -37.2%. For fiscal 2019 it was 30.4%, against 7.6% the year before. The highest annual figure on record is 73.5% in fiscal 2014.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | 30.4% | +22.7 |
| FY2018 | Dec 31, 2018 | 7.6% | −20.6 |
| FY2017 | Dec 31, 2017 | 28.3% | −35.1 |
| FY2016 | Dec 31, 2016 | 63.4% | +8.4 |
| FY2015 | Dec 31, 2015 | 55.0% | −18.4 |
| FY2014 | Dec 31, 2014 | 73.5% | +26.9 |
| FY2013 | Dec 31, 2013 | 46.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | 52.4% | −7.4 |
| Q4 FY2019 | Dec 31, 2019 | -336.0% | −270.8 |
| Q3 FY2019 | Sep 30, 2019 | 32.2% | +17.7 |
| Q2 FY2019 | Jun 30, 2019 | 52.7% | +10.2 |
| Q1 FY2019 | Mar 31, 2019 | 59.8% | +58.2 |
| Q4 FY2018 | Dec 31, 2018 | -65.2% | −138.1 |
| Q3 FY2018 | Sep 30, 2018 | 14.5% | −46.8 |
| Q2 FY2018 | Jun 30, 2018 | 42.5% | −0.9 |
| Q1 FY2018 | Mar 31, 2018 | 1.6% | −59.8 |
| Q2 FY2017 | Jun 30, 2017 | 72.9% | +1.9 |
| Q1 FY2017 | Mar 31, 2017 | 61.2% | −11.7 |
| Q4 FY2016 | Dec 31, 2016 | 43.4% | – |
| Q3 FY2016 | Sep 30, 2016 | 61.4% | – |
| Q2 FY2016 | Jun 30, 2016 | 71.1% | – |
| Q1 FY2016 | Mar 31, 2016 | 72.9% | – |
See a number that looks wrong?